ALMR

ALMR has decisively broken its key support and closed below the 50-day SMA in a Stage 4 downtrend, with EMAs declining and clear follow-through to the downside. The medium-term bias remains bearish, reinforced by the active Support Failure pattern and a sequence of lower highs and lower lows. Short-term timing favors immediate sell-side engagement on continued weakness, while the long-term uptrend stays intact above the 200-day SMA. Execution is focused on participating in the ongoing breakdown.

• ↑Q2 2026 revenue of $29.4M (+82% YoY) driven by NULISA and ARGO HT
• ↑Consumables revenue hit $15.5M (+147% YoY), boosting recurring sales
• ↓Current P/S ratio of 25.11 raises valuation concerns versus growth